Linsen Ye

11PUBLICATIONS

38CO-AUTHORS

Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersHuman impacts of climate change and human adaptation

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (11)

Sort by Publication Date:

|Jul 03, 2026

Glucagon-like peptide-1 receptor agonists versus dipeptidyl peptidase-4 inhibitors after liver resection for hepatocellular carcinoma in patients with type 2 diabetes: a target trial emulation study.

|Apr 24, 2026

Hepatic Stellate Cell-Specific METTL3 Deficiency Promotes Hepatocellular Carcinoma Progression via BMP10-SMAD1/5/8 Signaling.

|Apr 15, 2026

N6-methyladenosine-mediated up-regulation of ARRB2 regulates intrahepatic cholangiocarcinoma malignant progression and pemigatinib resistance through MAPK and Hippo signaling pathways.

|Nov 28, 2025

FXR-mediated antigen-specific CD8<sup>+</sup> T cell enhances antitumor immunity in intrahepatic cholangiocarcinoma.

Shanshan Liu, Zhixing Liang, Lisi Zhu

|Apr 03, 2024

Cold-induced FOXO1 nuclear transport aids cold survival and tissue storage.

Xiaomei Zhang, Lihao Ge, Guanghui Jin

|Nov 24, 2023

Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8<sup>+</sup> exhausted-like T cells.

Siqi Li, Kun Li, Kang Wang

Pageof 2

Frequent Collaborators

Wei Liu

Hua Li

Rongqiang Liu

Shuqun Cheng

Tianxing Dai

Guoying Wang

Yan Xu

Yong-Yi Zeng

Jian-Hua Rao

Qing-Qiang Ni

Frequent Collaborators

Wei Liu

Hua Li

Rongqiang Liu

Shuqun Cheng